Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Fischer

Showing results (281-290 of 302) with videos related to

Pageof 31
Sort By:
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
Pharmaceutical Research|January 12, 2017
Detection and Specific Elimination of EGFR<sup>+</sup> Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic ApproachDirk Bauerschlag, Ivo Meinhold-Heerlein, Nicolai Maass, et al.
International Journal of Cancer|June 5, 2015
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemiaRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
Oncotarget|August 27, 2016
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivoRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
Cellular Microbiology|March 8, 2014
Perforin-like protein PPLP2 permeabilizes the red blood cell membrane during egress of Plasmodium falciparum gametocytesChristine C Wirth, Svetlana Glushakova, Matthias Scheuermayer, et al.
EMBO Reports|July 5, 2005
Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plantsJulian K-C Ma, Eugenia Barros, Ralph Bock, et al.
Oncotarget|July 25, 2016
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demandManal Amoury, Dirk Bauerschlag, Felix Zeppernick, et al.
Chemical Communications (Cambridge, England)|December 6, 2018
Biocatalytically induced surface modification of the tobacco mosaic virus and the bacteriophage M13Valentina Vignali, Barbara S Miranda, Irene Lodoso-Torrecilla, et al.
Malaria Journal|February 7, 2016
Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malariaOtchere Addai-Mensah, Melanie Seidel, Nafiu Amidu, et al.
International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.
Pageof 31

Showing results (281-290 of 302) with videos related to

Sort By:
Pageof 31
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
Pharmaceutical Research|January 12, 2017
Detection and Specific Elimination of EGFR<sup>+</sup> Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic ApproachDirk Bauerschlag, Ivo Meinhold-Heerlein, Nicolai Maass, et al.
International Journal of Cancer|June 5, 2015
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemiaRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
Oncotarget|August 27, 2016
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivoRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
Cellular Microbiology|March 8, 2014
Perforin-like protein PPLP2 permeabilizes the red blood cell membrane during egress of Plasmodium falciparum gametocytesChristine C Wirth, Svetlana Glushakova, Matthias Scheuermayer, et al.
EMBO Reports|July 5, 2005
Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plantsJulian K-C Ma, Eugenia Barros, Ralph Bock, et al.
Oncotarget|July 25, 2016
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demandManal Amoury, Dirk Bauerschlag, Felix Zeppernick, et al.
Chemical Communications (Cambridge, England)|December 6, 2018
Biocatalytically induced surface modification of the tobacco mosaic virus and the bacteriophage M13Valentina Vignali, Barbara S Miranda, Irene Lodoso-Torrecilla, et al.
Malaria Journal|February 7, 2016
Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malariaOtchere Addai-Mensah, Melanie Seidel, Nafiu Amidu, et al.
International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.
Pageof 31